Cargando…

Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma

BACKGROUND: Burkitt lymphoma (BL) is an aggressive B-cell lymphoma, with a characteristic clinical presentation, morphology and immunophenotype. Over the past years, the typical translocation t(8;14) and its variants have been considered the molecular hallmark of this tumor. However, BL cases with n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Onnis, Anna, De Falco, Giulia, Antonicelli, Giuseppina, Onorati, Monica, Bellan, Cristiana, Sherman, Omar, Sayed, Shaheen, Leoncini, Lorenzo
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945769/ https://www.ncbi.nlm.nih.gov/pubmed/20930934 http://dx.doi.org/10.1371/journal.pone.0012960

Ejemplares similares

Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation
por: De Falco, Giulia, et al.
Publicado: (2015)

Interplay between HIV and microRNAs in AIDS-related lymphomas
por: De Falco, Giulia, et al.
Publicado: (2010)

Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma
por: Onnis, A, et al.
Publicado: (2012)

Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases
por: Mundo, Lucia, et al.
Publicado: (2017)

HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas
por: Luzzi, Anna, et al.
Publicado: (2014)

Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas
por: Piccaluga, Pier Paolo, et al.
Publicado: (2015)

Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma
por: Amato, Teresa, et al.
Publicado: (2016)

The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma
por: Ambrosio, Maria Raffaella, et al.
Publicado: (2014)

The Alteration of Lipid Metabolism in Burkitt Lymphoma Identifies a Novel Marker: Adipophilin
por: Ambrosio, Maria R., et al.
Publicado: (2012)

Current understanding of the role and regulation of miRNAs in Burkitt lymphoma
por: Videtta, Alessandro Davide, et al.
Publicado: (2018)

Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma
por: Abate, Francesco, et al.
Publicado: (2015)

Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases
por: Mundo, Lucia, et al.
Publicado: (2019)

HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in AIDS-related diffuse large B-cell and Burkitt lymphomas
por: Nyagol, J., et al.
Publicado: (2008)

The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma
por: Navari, Mohsen, et al.
Publicado: (2015)

MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas
por: Aquino, Gabriella, et al.
Publicado: (2013)

Epstein–Barr virus positivity as a defining pathogenetic feature of Burkitt lymphoma subtypes
por: Leoncini, Lorenzo
Publicado: (2021)

Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma
por: Seitz, Volkhard, et al.
Publicado: (2011)

Developments in Burkitt’s lymphoma: novel cooperations in oncogenic MYC signaling
por: Spender, Lindsay C, et al.
Publicado: (2014)

EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma
por: Mannucci, Susanna, et al.
Publicado: (2012)

Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
por: Poole, Candace J., et al.
Publicado: (2018)

The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS
por: Grygalewicz, Beata, et al.
Publicado: (2018)

MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma
por: Ambrosio, Maria Raffaella, et al.
Publicado: (2017)

Tuberous sclerosis complex is required for tumor maintenance in MYC‐driven Burkitt's lymphoma
por: Hartleben, Götz, et al.
Publicado: (2018)

Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature
por: Woroniecka, Renata, et al.
Publicado: (2022)

Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma
por: Bagaloni, Irene, et al.
Publicado: (2021)

The CT-Element of The C-Myc Gene Does Not Predispose to Chromosomal Breakpoints in Burkitt'S Lymphoma
por: Weber, Achim, et al.
Publicado: (2006)

Pathobiologic Roles of Epstein–Barr Virus-Encoded MicroRNAs in Human Lymphomas
por: Navari, Mohsen, et al.
Publicado: (2018)

Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
por: Kleo, Karsten, et al.
Publicado: (2019)

TNFAIP3(A20) genetic alterations in AIDS-related lymphomas
por: Giulino, Lisa, et al.
Publicado: (2010)

How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
por: Allday, Martin J.
Publicado: (2009)

Molecular mechanism of c‐Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma
por: Li, Ting, et al.
Publicado: (2020)

Modulation of Cellular MicroRNA by HIV-1 in Burkitt Lymphoma Cells—A Pathway to Promoting Oncogenesis
por: Ramorola, Beatrice Relebogile, et al.
Publicado: (2021)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
por: Navari, Mohsen, et al.
Publicado: (2014)

Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
por: Ayers, LW, et al.
Publicado: (2009)

Burkitt Lymphoma in the Mouse
por: Kovalchuk, Alexander L., et al.
Publicado: (2000)

Burkitt Lymphoma of the Duodenum
por: Matsueda, Katsunori, et al.
Publicado: (2017)

Burkitt's lymphoma of the mandible
por: Kuo, Ying-Shiung, et al.
Publicado: (2017)

Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation
por: Vance, Gail H, et al.
Publicado: (2023)

Silencing Human Rb2/p130 with shRNA
por: Leucci, Eleonora, et al.
Publicado: (2007)

Burkitt’s Lymphoma of the Rectosigmoid and Stomach Presenting as Hematochezia
por: Bustamante-Bernal, Marco, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nbfjo5fbgre2065cptom9oe4o1